Resistance to Targeted Therapies in Breast Cancer - - Books - Springer International Publishing AG - 9783319701417 - December 13, 2017
In case cover and title do not match, the title is correct

Resistance to Targeted Therapies in Breast Cancer 1st ed. 2017 edition

Price
Íkr 19,059
excl. VAT

Ordered from remote warehouse

Expected delivery Jul 31 - Aug 10

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Not rated yet

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling).

184 pages, 12 Illustrations, black and white; XV, 184 p. 12 illus.

Media Books     Book
Released December 13, 2017
ISBN13 9783319701417
Publishers Springer International Publishing AG
Pages 184
Dimensions 150 × 220 × 20 mm   ·   462 g
Language German  
Editor Prosperi, Jenifer R.

More from the same publisher